Skip to Main Content


Skip Nav Destination

Abstract CT170: Phase 1 study to characterize the pharmacokinetics and safety of tazemetostat in b-cell lymphomas or advanced solid tumors

Cancer Res (2020) 80 (16_Supplement): CT170.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal